Oxytocin levels predict HPA-axis response to selective serotonin reuptake inhibitors (SSRIs) in patients with major depression

被引：0
|
作者：
Keating, C. [1 ]
Dawood, T. [2 ]
Lambert, G.
Barton, D.
Kulkarni, J. [1 ]
Tilbrook, A.
机构：
[1] Monash Univ, Melbourne, Vic 3004, Australia
[2] Baker IDI, Melbourne, Vic, Australia
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2010年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：152 / 152
页数：1
相关论文
共 50 条
  • [21] HPA-AXIS HORMONE MODULATION OF STRESS RESPONSE CIRCUITRY ACTIVITY IN WOMEN WITH REMITTED MAJOR DEPRESSION
    Holsen, L. M.
    Lancaster, K.
    Klibanski, A.
    Whitfield-Gabrieli, S.
    Cherkerzian, S.
    Buka, S.
    Goldstein, J. M.
    NEUROSCIENCE, 2013, 250 : 733 - 742
  • [22] Electroencephalography (EEG) spectral signatures of selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs) and vortioxetine in major depressive disorder: A systematic review
    Le, Gia Han
    Wong, Sabrina
    Lu, Andy
    Vasudeva, Shreya
    Gill, Hartej
    Badulescu, Sebastian
    Portelles, Daylen Rodriguez
    Zheng, Yang Jing
    Teopiz, Kayla M.
    Meshkat, Shakila
    Kwan, Angela T. H.
    Ho, Roger
    Rhee, Taeho Greg
    Rosenblat, Joshua D.
    Mansur, Rodrigo B.
    McIntyre, Roger S.
    JOURNAL OF AFFECTIVE DISORDERS, 2025, 368 : 798 - 819
  • [23] SECONDARY OSTEOPOROSIS IN PATIENTS WITH DEPRESSION TREATED WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS
    Boskovic, K. M.
    Zavisic, B. Kovacev
    Bosnjak, M. Cvjetkovic
    TomasevicTodorovic, S.
    Knezevic, A.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S464 - S464
  • [24] Effects of selective serotonin reuptake inhibitors on DNA damage in patients with depression
    Ahmadimanesh, Mahnaz
    Abbaszadegan, Mohammad Reza
    Morshedi Rad, Dorsa
    Moallem, Seyed Adel
    Mohammadpour, Amir Hooshang
    Ghahremani, Mohammad Hossein
    Farid Hosseini, Farhad
    Behdani, Fatemeh
    Akhondpour Manteghi, Ali
    Jowsey, Paul
    Shabani Behbahani, Fatemeh
    Moallem, Seyed Mohammad Hassan
    Etemad, Leila
    JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (11) : 1364 - 1376
  • [25] Interpersonal sensitivity and response to selective serotonin reuptake inhibitors in patients with acute major depressive disorder
    Peters, Evyn M.
    Yilmaz, Orhan
    Li, Cindy
    Balbuena, Lloyd
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 355 : 422 - 425
  • [26] Combination therapy with reboxetinefor major depression patients who are partial or nonresponders to serotonin selective reuptake inhibitors
    Rubio, G
    San, L
    García-García, P
    Alamo, C
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2003, 31 (06): : 315 - 324
  • [27] Rapid response to selective serotonin reuptake inhibitors in post-COVID depression
    Mazza, Mario Gennaro
    Zanardi, Raffaella
    Palladini, Mariagrazia
    Rovere-Querini, Patrizia
    Benedetti, Francesco
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2022, 54 : 1 - 6
  • [28] The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective
    Lynn Boschloo
    Fredrik Hieronymus
    Alexander Lisinski
    Pim Cuijpers
    Elias Eriksson
    Translational Psychiatry, 13
  • [29] The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective
    Boschloo, Lynn
    Hieronymus, Fredrik
    Lisinski, Alexander
    Cuijpers, Pim
    Eriksson, Elias
    TRANSLATIONAL PSYCHIATRY, 2023, 13 (01)
  • [30] Venlafaxine versus selective serotonin reuptake inhibitors in mixed major depression and dysthymic disorder
    Vasiliu, D.
    Vasiliu, O.
    Tudor, C.
    Patriche, D.
    Stanescu, B.
    Ojog, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S310 - S311
12345